2010 Annual Meeting | Frontiers in Clinical Neuroscience Plenary Session
| 08:00 AM - 11:00 AM |
Break
|
|
| 09:00 AM - 11:00 AM |
Reflections on Memory: What Neurosurgical Patients Have Taught Us
Brenda Milner, PhD |
|
| 09:00 AM - 11:00 AM |
Clinical Spectrum and Cellular Mechanisms of Autoimmunity to NMDA and Other Synaptic Receptors
Josep O. Dalmau, MD, PhD, FAAN |
|
| 09:00 AM - 11:00 AM |
Stroke and Alzheimer Disease: Fellow Travelers or Partners in Crime?
Vladimir Hachinski, MD, DSc, FAAN |
|
| 09:00 AM - 11:00 AM |
Neurologists Listening to Neurons: Intracortically-Based Brain-Computer Interfaces
Leigh R. Hochberg, MD, PhD, FAAN |
| Josep O. Dalmau, MD, PhD, FAAN | Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. |
| Vladimir Hachinski, MD, DSc, FAAN | Dr. Hachinski has nothing to disclose. |
| Brenda Milner, PhD | No disclosure on file |
| Leigh R. Hochberg, MD, PhD, FAAN | The institution of Dr. Hochberg has received research support from The MGH Translational Research Center has a clinical research support agreement (CRSA) with Axoft, Neuralink, Neurobionics, Precision Neuro, Synchron, and Reach Neuro, for which LRH provides consultative input. LRH is a non-compensated member of the Board of Directors of a nonprofit assistive communication device technology foundation (Speak Your Mind Foundation). Mass General Brigham (MGB) is convening the Implantable Brain-Computer Interface Collaborative Community (iBCI-CC); charitable gift agreements to MGB, including those received to date from Paradromics, Synchron, Precision Neuro, Neuralink, and Blackrock Neurotech, support the iBCI-CC, for which LRH provides effort.. The institution of Dr. Hochberg has received research support from Dr. Hochberg also receives research support from the US Department of Veterans Affairs and the National Institutes of Health.. Dr. Hochberg has received intellectual property interests from a discovery or technology relating to health care. |